Guardant Health (GH) Return on Capital Employed (2018 - 2026)
Guardant Health (GH) posted Return on Capital Employed of 29.86% for Q2 2026, down 11.58% sequentially from 26.76% in Q1 2026, and up 1204.0% YoY from 2.29% in Q2 2025.
Guardant Health (GH) Return on Capital Employed (2018 - 2026) Analysis & Trends
Guardant Health has reported Return on Capital Employed for 9 years, with the latest figure at 29.86% in Q2 2026.
- Quarterly Return on Capital Employed rose 1204.0% year-over-year to 29.86% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 29.86% (up 1204.0% YoY) and the FY2025 annual result came in at 30.22%, up 123.0% from the prior year.
- Return on Capital Employed retreated to 29.86% in Q2 2026 per GH's latest filing, from 26.76% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 22.0% in Q1 2022 and troughed at 41.9% in Q2 2025.
- A 5-year average of 34.09% and a median of 34.95% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed tumbled 1891 bps in 2023, then surged 1204 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 37.22% in 2022, then gained by 4 bps to 35.61% in 2023, then advanced by 3 bps to 34.48% in 2024, then advanced by 6 bps to 32.57% in 2025, then gained by 8 bps to 29.86% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 29.86%, 26.76%, and 32.57% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.85% |
| 10 | Guardant Health | 21.59 Bn | 20.53 Bn | 219.03 Mn | -29.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.86% |
| Mar 31, 2026 | -26.76% |
| Dec 31, 2025 | -32.57% |
| Sep 30, 2025 | -41.44% |
| Jun 30, 2025 | -41.90% |
| Mar 31, 2025 | -38.26% |
| Dec 31, 2024 | -34.48% |
| Sep 30, 2024 | -37.42% |
| Jun 30, 2024 | -35.14% |
| Mar 31, 2024 | -34.77% |
| Dec 31, 2023 | -35.61% |
| Sep 30, 2023 | -32.25% |
| Jun 30, 2023 | -36.91% |
| Mar 31, 2023 | -40.92% |
| Dec 31, 2022 | -37.22% |
| Sep 30, 2022 | -30.98% |
| Jun 30, 2022 | -25.17% |
| Mar 31, 2022 | -22.00% |
| Dec 31, 2021 | -20.34% |
| Sep 30, 2021 | -18.73% |